To investigate whether BTG3 affects the development of skin cancer, a 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoyl phorbol-13-acetate (TPA) two-stage skin carcinogenesis mouse model was employed [40] (Fig. 5b). This evidence concerns the gene BTG3 and skin cancer.